| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 19 |
| 1 | RITUXIMAB | 16 |
| 2 | ADALIMUMAB | 13 |
| 3 | DEXAMETHASONE | 12 |
| 4 | DEXAMETHASONE 1.5 MG | 12 |
| 5 | CYTARABINE | 11 |
| 6 | DOXORUBICIN | 11 |
| 7 | METHOTREXATE SODIUM | 11 |
| 8 | METHOTREXATE | 10 |
| 9 | INFLIXIMAB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAFARELIN ACETATE | 3 | 0.0110 |
| 1 | MAGESIUM CITRATE | 1 | 0.0109 |
| 2 | CHORIOGONADOTROPIN ALFA | 3 | 0.0011 |
| 3 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| 4 | VINORELBINE | 6 | 0.0009 |
| 5 | DACARBAZINE | 6 | 0.0008 |
| 6 | BLEOMYCIN SULFATE | 6 | 0.0006 |
| 7 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 8 | MEFENAMIC ACID | 1 | 0.0005 |
| 9 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gonadotropin [EPC] | 3 | 0.0014 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 2 | Progesterone [EPC] | 4 | 0.0002 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 9 | 0.0001 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Copper-containing Intrauterine Device [EPC] | 4 | 0.0001 |
| 7 | Progestin [EPC] | 23 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 9 | GLP-2 Analog [EPC] | 1 | 0.0001 |